Header Logo

Connection

DONALD BERRY to Pyrrolidines

Back to Details
This is a "connection" page, showing publications DONALD BERRY has written about Pyrrolidines.
DONALD BERRY
Connection Strength
0.128
Pyrrolidines
  1. Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease. Alzheimer Dis Assoc Disord. 2015 Jul-Sep; 29(3):192-9.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.